Addiction Policy Forum Blog

4 min read

The Impact of Racism and Mindfulness on Health

By Mark Gold, MD on June 20, 2019

A recent study brings forward some important insight into how racial discrimination affects behavioral health outcomes among young Black Americans. Read further to find out more about the negative impact of discrimination and how mindfulness may prove to be an effective strategy in mitigating associated health risks.

Continue Reading
1 min read

Ask a Counselor: What is an Intensive Outpatient Program (IOP)?

By Addiction Resource Center on May 29, 2019

Continue Reading
3 min read

The Paradox of Diverted Buprenorphine

By Mark Gold, MD on April 19, 2019

Buprenorphine, a μ-opioid (pronounced mu-opioid) receptor partial agonist, is a highly effective, evidence-based medication for treating opioid use disorders (OUD). In order to prescribe buprenorphine, qualifying practitioners must obtain a waiver from the Drug Enforcement Agency (DEA), which places strict limits on the number of patients they may treat annually. Previous legislation and regulation meant buprenorphine treatment existed nearly entirely outside the traditional healthcare system. Despite legislation that increases the number of patients a doctor can prescribe to, and allowing individual medical providers to become certified, there is still hesitation among many providers over becoming certified to prescribe the medication, many waivered physicians do not have many patients on buprenorphine - some waivered physicians have none at all.

Continue Reading